InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Fuhrman Alan, Director. Director active across 3 companies, notably SpringWorks Therapeutics, Inc.. In total, 5 disclosures have been logged. The latest transaction was filed on 19 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
04,818 shares0
Common Stock
SEC:0001104659-22-063507:0·
012,376 shares0
Common Stock
SEC:0001628280-21-011361·
012,376 shares0
Common Stock
SEC:0001628280-21-011361:0·
01,106 shares0
Common Stock
SEC:0001104659-21-070519·
01,106 shares0
Common Stock
SEC:0001104659-21-070519:0·
5 of 5 declarations
About Fuhrman Alan
Alan Fuhrman is a Board Member at SpringWorks Therapeutics, Inc. and Esperion Therapeutics, Inc. With a solid background in the biopharmaceutical sector, he participates in strategic decision-making and oversight of the operations of these companies. His role as a board member allows him to provide valuable insights into market challenges and opportunities. Alan Fuhrman is committed to supporting the mission of these companies while ensuring sustainable development and growth.
